Tristan Marshall is a notable inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of formulations for antigen binding proteins. With a total of three patents to his name, Marshall's work is recognized for its potential impact on medical treatments.

Latest Patents

Among his latest patents, Marshall has developed high concentration anti-BLyS pharmaceutical formulations. This invention relates to pharmaceutical formulations of a pharmaceutically active antigen binding protein, such as a monoclonal antibody. These formulations include a buffering agent and a tonicity agent, enhancing their effectiveness. Another significant patent is the BLyS antibody formulation, which shares similar characteristics and applications as his previous work.

Career Highlights

Tristan Marshall is currently employed at GlaxoSmithKline Intellectual Property Management Limited. His role at this prominent company allows him to further his research and development efforts in the pharmaceutical industry. His innovative approach and dedication to improving medical formulations have positioned him as a valuable asset in his field.

Collaborations

Marshall collaborates with talented professionals, including Angela Blake-Haskins and Melissa D. Perkins. These partnerships foster a creative environment that enhances the development of groundbreaking pharmaceutical solutions.

Conclusion

Tristan Marshall's contributions to pharmaceutical formulations demonstrate his commitment to innovation and improvement in medical treatments. His patents reflect a deep understanding of the complexities involved in developing effective therapies.

This text is generated by artificial intelligence and may not be accurate.